Login

IsoRay, Inc ISR CEO Lori Woods on 2020 Results - Lori Woods , CEO, IsoRay Inc 00:00:00

Share On Facebook Share On Twitter

IsoRay, Inc ISR CEO Lori Woods on 2020 Results - Lori Woods , CEO, IsoRay Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Ace Technologies - PARTNER Testimonials | Koo Gwan Young, CEO, Ace Technologies Corp8880K:KOE
00:10:00
JCPenney Faces Challenges with Cash Flow and Customer Engagement Amid Strategy Shift
00:10:00
Ceapro's patented process technologies include Pressurized Gas eXpanded technology|Gilles Gagnon,President,Ceapro Inc
00:00:00
Mike Lampron Chief Executive Officer,Mach7 Technologies Ltd
00:10:00
Mike Crawley, CEO of Northland Power, joins BNN Bloomberg to discuss recent company updates, developments, and upcoming projects.
00:10:00
NextSource Materials: Advancing Madagascar's Premier Graphite Project for Global Markets
00:00:00
Understanding pertussis, or whooping cough - Nipunie Rajapakse, M.D., Mayo Clinic
00:10:00
Roger McNamee Discusses Netflix's Position Amidst Streaming Competition and Regulatory Challenges |Roger McNamee, Co-Founder, Elevation Partners.
00:10:00
ISG Presentation at NobleCon17: Driving Global Technology Transformation | Michael P. Connors - Chairman & CEO of Information Services Group, Inc.
00:10:00
Quazi Mohammad Shahed, CEO of Partex Star Group, discusses with Somoy TV at Complex-1.
00:10:00
Capita CEO Jon Lewis discusses the appointment of employees to the board in an interview with Bloomberg TV.
00:10:00
Fostering Industry-Union Collaboration for a Net-Zero Skills Agenda | Chris O'Shea, CEO,Centrica PLC.

© 2017 - Neuhu+